| Market Cap | ₹41Cr | 
| ROE | 90.88% | 
| P/E Ratio(TTM) | -1.83 | 
| EPS(TTM) | -2.68 | 
| P/B Ratio | 0.00 | 
| Dividend Yield | 0.00% | 
| Industry P/E | 34.63 | 
| Book Value | -8.82 | 
| Debt to Equity | -10.70 | 
| Face Value | 2 | 
| Parent Organisation | Vivimed Labs Limited | 
| Managing Director | Mr. Santosh Varalwar | 
| BSE Symbol | 532660 | 
| COMPANY | 52 WEEK  | MARKET PRICE | P/E Ratio  | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%)  | 86.40  | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%)  | 39.18  | ||
| Emcure Pharmaceuticals | NA (0.00%)  | 32.65  | ||
| Wockhardt | NA (0.00%)  | -450.62  |